Shubham Yadav is a PhD candidate at the MIT Media Lab, where he leverages his expertise in nanoelectronics, bioengineering, and neurotechnology to develop cutting-edge solutions at the intersection of healthcare and advanced technology. With a strong academic foundation, including an M.S. from MIT and a B.Tech-M.Tech from IIT Kanpur, Shubham has contributed to groundbreaking research in non-invasive therapeutic devices, early-stage disease detection, and neural interface technologies. His work has been featured in high-impact journals such as Nature Biotechnology and IEEE Transactions on Antennas & Propagation. As the co-founder of Lotus, an AI-powered platform designed to revolutionize clinical trials, Shubham is addressing critical challenges in patient recruitment and retention. Lotus integrates advanced AI voice agents and real-time data analysis to streamline patient eligibility identification and foster proactive communication, enabling pharmaceutical companies and clinical trial sites to operate within a single intelligent framework. Shubham’s entrepreneurial vision is driven by his commitment to transforming healthcare through innovation. His diverse skill set spans neurotechnology, nanotechnology and software development, making him uniquely positioned to bridge the gap between cutting-edge research and impactful real-world applications.